| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 09/20/2001 | US20010023247 Photodynamic therapy |
| 09/20/2001 | US20010022970 Halogenated xanthan compound |
| 09/19/2001 | EP1133319A1 Photosensitizer conjugates for targeting intracellular pathogens |
| 09/18/2001 | US6291215 Inhibitory effects on synthetic and natural colorants on carcinogenes |
| 09/18/2001 | US6290712 Laser/sensitizer assisted immunotherapy |
| 09/13/2001 | WO2001066550A2 Compounds for pdt |
| 09/13/2001 | WO2001066030A1 Methods and apparatus for optical imaging |
| 09/13/2001 | US20010021370 Parasiticides, antiprotozoa agent |
| 09/13/2001 | CA2402433A1 Compounds for pdt |
| 09/12/2001 | EP1131100A2 Therapeutic compositions for metabolic bone disorders or bone metastases |
| 09/12/2001 | EP1131099A2 Noninvasive vascular therapy |
| 09/11/2001 | US6288053 Use of protein kinase C inhibitors to enhance the clinical efficacy of radiation therapy |
| 09/07/2001 | WO2001064228A1 Method for producing a bioactive substance from blood serum |
| 09/06/2001 | US20010019709 Polyaminocarboxilic acids used in tumor therapy |
| 09/05/2001 | EP1128837A2 Method for preventing and reversing atherosclerosis in mammals |
| 09/05/2001 | EP1128812A1 Nano-emulsion of 5-aminolevulinic acid |
| 09/05/2001 | CN1311692A Farnesyl protein transferase inhibitors with i(IN VIVO) Radiosensitizing |
| 09/04/2001 | US6284751 Carpal tunnel syndrome; adult respiatory suystem disorders; antitumor agents |
| 09/04/2001 | US6284280 Microparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their production |
| 09/04/2001 | US6284224 Inhibitory effect of synthetic and natural colorants on carcinogenesis |
| 09/04/2001 | US6283956 Reduction, elimination, or stimulation of hair growth |
| 08/30/2001 | WO2001062289A2 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| 08/30/2001 | WO2001062245A2 Bilirubin or biliverdin degradation fragments |
| 08/30/2001 | WO2001062207A2 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 08/30/2001 | WO2001062156A1 Novel indocyanine dyes |
| 08/30/2001 | WO2001003492A3 Device and method for acting on microorganisms |
| 08/30/2001 | WO2000044682A9 Biodegradable glass compositions and methods for radiation therapy |
| 08/30/2001 | US20010018072 Solid matrix therapeutic compositions |
| 08/30/2001 | US20010018041 Lymphomas, leukemia |
| 08/30/2001 | CA2399550A1 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 08/29/2001 | EP1127265A1 Method for non-invasive imaging oxygen distribution in multi-dimensions and apparatus therefor |
| 08/29/2001 | EP1126884A2 Radiodense compositions |
| 08/29/2001 | EP1126879A1 Gene therapy for regulating smooth muscle cell tone |
| 08/29/2001 | EP1126782A1 Method for improved imaging and photodynamic therapy |
| 08/29/2001 | CN1310596A Improved methods and apparatus for multi-photon photo-activation of therapeutic agents |
| 08/28/2001 | US6281223 Coadministering x-ray radiation and orally dosed 9-nitrocamptothecin |
| 08/23/2001 | WO2001060365A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug |
| 08/23/2001 | WO2001060360A1 Photodynamic therapy for selectively closing neovasa in eyeground tissue |
| 08/23/2001 | WO2001008704A3 Dendrimer-photosensitizer complexes for medical applications |
| 08/23/2001 | US20010016760 Use of 5-aminolevulinic acid or a derivate thereof for photodynamic diagnosis and/or photodynamic therapy |
| 08/23/2001 | CA2400197A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug |
| 08/22/2001 | EP1124982A1 THE HEMATOPOIETIC, MYELOPROTECTING, ANTITUMOR IMMUNE CELLS GENERATING AND RADIOSENSITIZING POLYSACCHARIDE ISOLATED FROM i PANAX GINSENG /i |
| 08/22/2001 | EP1124607A1 Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport |
| 08/22/2001 | EP1124580A1 Enhanced radiation therapy |
| 08/21/2001 | US6277844 Administering a benzodiazepine derivative for treatment of breast, prostate and glial cell cancer |
| 08/21/2001 | US6277378 Inhibitory effect of synthetic and natural colorants on carcinogenesis |
| 08/21/2001 | CA2018751C Stable freeze dried polyhematoporphyrin ether/ester composition |
| 08/16/2001 | WO2001058458A1 Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| 08/16/2001 | WO2001058452A1 Thermal ablation of tissue |
| 08/16/2001 | WO2001058434A2 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents |
| 08/16/2001 | WO2001058240A2 Photodynamic therapy for treating conditions of the eye |
| 08/16/2001 | CA2714081A1 Methods and compositions for treating conditions of the eye |
| 08/16/2001 | CA2400092A1 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents |
| 08/16/2001 | CA2398296A1 Method for loading a red blood cell with an agent |
| 08/15/2001 | CN1307904A Near infrared ray irradiation method for cosmetics and its application |
| 08/14/2001 | US6275726 Methods of enhanced light transmission through turbid biological media |
| 08/14/2001 | US6274729 Prevent tissue damage |
| 08/14/2001 | US6274614 Methods, compositions and articles for reducing or preventing the effects of inflammation |
| 08/14/2001 | US6274604 Alteration of circadian rhythmicity with a tachykinin antagonist |
| 08/14/2001 | US6274121 Superparamagnetic particles, process for their manufacture and use |
| 08/14/2001 | US6274116 Compositions for boron delivery to mammalian tissue |
| 08/14/2001 | US6274086 Matrix comprising arrays of excitation light-transmitting optical fibers and phosphorescence-detecting/transmitting optical fibers whereby pulses of light are sequentially emitted and phosphorescence detected at a plurality of sites |
| 08/09/2001 | WO2001056546A2 Magnetoliposome composition for targeted treatment of biological tissue |
| 08/09/2001 | WO2000070085A3 Method for detecting the effect of different chemotherapeutic agents and/or radiation therapy in malignant diseases |
| 08/09/2001 | US20010012885 Conjugate consisting of an active substance and a non-exogeneous native protein |
| 08/09/2001 | US20010012522 Multilayer; shell, core |
| 08/09/2001 | DE19953517C1 Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation Use of treosulphan for conditioning of patients before Knochemarktransplantation or blood stem cell transplantation |
| 08/08/2001 | EP1121111A2 Compounds for the treatment of weight loss |
| 08/08/2001 | EP1019037B1 Medicament containing delta-aminolevulinic acid |
| 08/08/2001 | CN1307492A Device for protection against the sun and application of substance to skin |
| 08/08/2001 | CN1307473A Triterpene compositions and methods for use thereof |
| 08/07/2001 | US6271250 Metal Glycididaagolc, and preparation and uses thereof |
| 08/07/2001 | US6271211 Muscle contraction |
| 08/07/2001 | US6270749 Use of Texaphyrin in ocular diagnosis and therapy |
| 08/07/2001 | US6269818 Photoactivation of endogenous porphyrins for treatment of psoriasis |
| 08/04/2001 | CA2298041A1 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 08/02/2001 | WO2001055151A1 Polymeric micellar structure |
| 08/02/2001 | WO2001055092A2 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 08/02/2001 | DE10003620A1 Non-aqueous solution or suspension of 5-aminolevulinic acid, is useful in the treatment or diagnosis of tumor diseases or psoriasis by photodynamic therapy |
| 08/01/2001 | EP1120119A1 Remedies for photochemotherapy |
| 08/01/2001 | EP0633786B1 Method of inactivation of viral, parasitic and bacterial blood contaminants |
| 08/01/2001 | CN1306442A Improement in or relating to contrast agents |
| 07/31/2001 | US6267946 Cultivating epstein-barr virus(ebv) genome-carrying cells in presence of tumor-promoting chemical or tumor-inducing chemical; treating ebv genome-carrying cells with synthetic colorant to reduce early antigen induction |
| 07/31/2001 | US6267933 Methods of preparing and using electrostatically treated fluids |
| 07/31/2001 | CA2237263C Radionuclide labeling of vitamin b12 and coenzymes thereof |
| 07/26/2001 | WO2001053300A1 Porphyrins and related compounds |
| 07/26/2001 | WO2001053292A1 Dendrimer precursor dyes for imaging |
| 07/26/2001 | WO2001052870A1 Treatment of congestive heart failure by pretreated autologous blood |
| 07/26/2001 | WO2001052814A1 Local drug delivery using photosensitizer-mediated and electromagnetic radiation-enhanced vascular permeability |
| 07/26/2001 | WO2001052746A1 Versatile hydrophilic dyes |
| 07/26/2001 | WO2001052745A1 Novel dyes |
| 07/26/2001 | WO2001052743A1 Tunable indocyanine dyes for biomedical applications |
| 07/26/2001 | US20010009903 Roasting process using far infrared radiation, microorganism fermentation to produce peroxide lipid thereby improving antitumor activity |
| 07/26/2001 | US20010009663 Non-lethal methods for conditioning a recipient for bone marrow transplantation |
| 07/26/2001 | CA2399217A1 Porphyrins and related compounds |
| 07/26/2001 | CA2397333A1 Local drug delivery using photosensitizer-mediated and electromagnetic radiation-enhanced vascular permeability |
| 07/25/2001 | EP1117665A1 Photosensitizers for photodynamic applications |
| 07/24/2001 | US6264920 Tunable indocyanine dyes for biomedical applications |
| 07/24/2001 | US6264919 Restoring fluorescence; adding biocompatible solvent |
| 07/19/2001 | WO2001051494A1 Inhibitors of prenyl-protein transferase |